Acutaas Chemicals (NSE:ACUTAAS) Other Current Liabilities: ₹0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACUTAAS Acutaas Chemicals Ltd NSE:ACUTAAS
70 GF Score
Price ₹3,619.40
GF Value ₹1,327.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Acutaas Chemicals Other Current Liabilities?

Acutaas Chemicals NSE:ACUTAAS +0.99% 70 Other Current Liabilities is ₹0 Mil as of Dec. 2025. GuruFocus rates NSE:ACUTAAS with a GF Score™ of 70/100 and a GF Value™ of ₹1,327.57 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Acutaas Chemicals's other current liabilities for the quarter that ended in Dec. 2025 was ₹0 Mil.

Acutaas Chemicals's quarterly other current liabilities increased from Jun. 2025 (₹0 Mil) to Sep. 2025 (₹665 Mil) but then declined from Sep. 2025 (₹665 Mil) to Dec. 2025 (₹0 Mil).

Acutaas Chemicals's annual other current liabilities declined from Mar. 2023 (₹150 Mil) to Mar. 2024 (₹132 Mil) but then increased from Mar. 2024 (₹132 Mil) to Mar. 2025 (₹251 Mil).

Acutaas Chemicals Other Current Liabilities Related Terms

Acutaas Chemicals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Acutaas Chemicals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acutaas Chemicals Other Current Liabilities Chart

Acutaas Chemicals Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Other Current Liabilities
Get a 7-Day Free Trial 25.59 61.54 150.26 131.96 250.99

Acutaas Chemicals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 250.99 0.00 664.74 0.00
NSE:ACUTAAS
70GF Score
Acutaas Chemicals Ltd NSE:ACUTAAS
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acutaas Chemicals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹0 Mil mean?
Acutaas Chemicals (NSE:ACUTAAS) has a Other Current Liabilities of ₹0 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Acutaas Chemicals.
Is Acutaas Chemicals' Other Current Liabilities too high?
Acutaas Chemicals' current Other Current Liabilities is ₹0 Mil. Overall, Acutaas Chemicals has a GF Score™ of 70/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acutaas Chemicals' Other Current Liabilities compare to LIN and SHW?
Acutaas Chemicals' Other Current Liabilities of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Chemicals company?
A good Other Current Liabilities depends on the Chemicals industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Acutaas Chemicals. Acutaas Chemicals's current Other Current Liabilities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutaas Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Acutaas Chemicals (NSE:ACUTAAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,327.57, compared to a current price of ₹3,619.40 — trading 172.6% above its estimated fair value. The current Other Current Liabilities is ₹0 Mil. Acutaas Chemicals' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Acutaas Chemicals (NSE:ACUTAAS), the current Other Current Liabilities is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?

Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued. The current stock price of ₹3,619.40 is trading 172.6% above its estimated GF Value™ of ₹1,327.57. GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.

Key valuation signals for NSE:ACUTAAS:

  • Other Current Liabilities: ₹0 Mil
  • GF Value™: ₹1,327.57 vs. price of ₹3,619.40 (172.6% above fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Acutaas Chemicals Business Description

Other Exchanges 543349:India
Address Road No 82/A & 82/C, Plot No. 440/4, 5 & 6, 8206-B, 478, 479 & 494, 495, GIDC Sachin, District Surat, Surat, GJ, IND, 394230
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
70GF Score

Get the complete analysis for NSE:ACUTAAS

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹3,619.40
Price
₹1,327.57
GF Value